FDA advisory committees will begin hearings on drug aimed at osteoarthritis pain
Two FDA advisory committees will begin meeting Wednesday on a Pfizer drug called tanezumab that could bring relief for osteoarthritis pain.
Two FDA advisory committees will begin meeting Wednesday on a Pfizer drug called tanezumab that could bring relief for osteoarthritis pain.